Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the University of Southern California …

AP Mitra, J Cai, G Miranda, S Bhanvadia… - The Journal of …, 2022 - auajournals.org
Purpose: There are conflicting reports on outcome trends following radical cystectomy (RC)
for bladder cancer. Materials and Methods: Evolution of modern bladder cancer …

Racial and socioeconomic disparities in bladder cancer survival: analysis of the California Cancer Registry

JM Sung, JW Martin, FA Jefferson, DA Sidhom… - Clinical genitourinary …, 2019 - Elsevier
Abstract Purpose To examine the California Cancer Registry (CCR) for bladder cancer
survival disparities based on race, socioeconomic status (SES), and insurance in California …

CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic …

Y Xiong, F Huang, X Li, Z Chen… - International …, 2017 - spandidos-publications.com
Lymph node metastasis in patients with urinary bladder cancer (UBC) is always associated
with poor prognosis and is the determinant for tumor staging and the development of …

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis

K Mori, T Yanagisawa, S Katayama, E Laukhtina… - World journal of …, 2023 - Springer
Purpose To assess the prognostic value of sex for non-muscle-invasive/muscle-invasive
bladder urothelial carcinoma (NMIBC/MIBC) treated with radical surgery. Methods The …

Evaluation of the Hybrid Tracer Indocyanine Green–99mTc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer—A Prospective Pilot Study

DDD Rietbergen, EJ van Gennep… - Clinical Nuclear …, 2022 - journals.lww.com
Methods Twenty histologically confirmed cN0M0 MIBC patients (mean age, 63.3 years;
range, 30–82 years), scheduled for radical cystectomy with SN biopsy and extended pelvic …

Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis

C Fang, L Xu, W He, J Dai, F Sun - Cell cycle, 2019 - Taylor & Francis
Long noncoding RNA (lncRNA) regulate many biological processes ranging from
tumorigenesis to cancer metastasis. MicroRNA-223 (miR-223) acts as a novel tumor …

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: an update from the National Cancer Data Base …

AB Weiner, MK Keeter, A Manjunath… - … Oncology: Seminars and …, 2018 - Elsevier
Introduction We sought to characterize national disparities in the diagnosis of advanced
stage bladder cancer. Among patients with advanced disease, we explored disparities in …

Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity

F Chierigo, M Borghesi, C Würnschimmel… - … Urology and Nephrology, 2022 - Springer
Purpose to compare observed overall survival vs age-adjusted lifetable (LT) derived life
expectancy (LE) in metastatic urothelial bladder cancer (MBCa) patients according to …

[HTML][HTML] Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery

M Abufaraj, K Gust, M Moschini, B Foerster… - Translational …, 2016 - ncbi.nlm.nih.gov
Locally advanced (T3b, T4 and N1− N3) and metastatic urothelial bladder cancer (BCa) is a
lethal disease with poor survival outcomes. Combination chemotherapy remains the …

[HTML][HTML] NF-κB p65 overexpression promotes bladder cancer cell migration via FBW7-mediated degradation of RhoGDIα protein

J Zhu, Y Li, C Chen, J Ma, W Sun, Z Tian, J Li, J Xu… - Neoplasia, 2017 - Elsevier
BACKGROUND: Since invasive bladder cancer (BC) is one of the most lethal urological
malignant tumors worldwide, understanding the molecular mechanisms that trigger the …